SWOG
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1956-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.swog.org
S0125, Chemotherapy, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Older Patients With Acute Myeloid Leukemia
- Conditions
- Leukemia
- Interventions
- Biological: therapeutic allogeneic lymphocytesProcedure: peripheral blood stem cell transplantationRadiation: radiation therapy
- First Posted Date
- 2003-01-28
- Last Posted Date
- 2015-03-25
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 5
- Registration Number
- NCT00053014
- Locations
- 🇺🇸
CCOP - Atlanta Regional, Atlanta, Georgia, United States
🇺🇸University of Mississippi Medical Center, Jackson, Mississippi, United States
🇺🇸USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
S9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy
- Conditions
- Prostate Cancer
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2014-02-25
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 770
- Registration Number
- NCT00004001
- Locations
- 🇺🇸
CCOP - Cedar Rapids Oncology Project, Cedar Rapids, Iowa, United States
🇺🇸Mayo Clinic, Jacksonville, Florida, United States
🇺🇸CCOP - Iowa Oncology Research Association, Des Moines, Iowa, United States
S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
- Conditions
- Prostate Cancer
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2022-12-30
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 983
- Registration Number
- NCT00004124
- Locations
- 🇺🇸
Cancer Care Center at Advocate Lutheran Hospital, Park Ridge, Illinois, United States
🇺🇸Alta Bates Comprehensive Cancer Center, Berkeley, California, United States
🇺🇸Bismarck Cancer Center, Bismarck, North Dakota, United States
S0028, Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary Tract
- Conditions
- Transitional Cell Cancer of the Renal Pelvis and UreterBladder CancerUrethral Cancer
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2016-08-11
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 65
- Registration Number
- NCT00022633
- Locations
- 🇺🇸
Mobile Infirmary Medical Center, Mobile, Alabama, United States
🇺🇸Holland Community Hospital, Holland, Michigan, United States
🇺🇸Munson Medical Center, Traverse City, Michigan, United States
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
- Conditions
- Ovarian CancerPeritoneal Cavity Cancer
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2015-10-26
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 61
- Registration Number
- NCT00043082
- Locations
- 🇺🇸
USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
🇺🇸CCOP - Atlanta Regional, Atlanta, Georgia, United States
🇺🇸Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
S0000 Selenium and Vitamin E in Preventing Prostate Cancer
- Conditions
- Prostate Cancer
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2015-11-20
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 35533
- Registration Number
- NCT00006392
- Locations
- 🇺🇸
Bethesda North Hospital, Cincinnati, Ohio, United States
🇺🇸Good Samaritan Hospital Cancer Treatment Center, Cincinnati, Ohio, United States
🇺🇸Tod Children's Hospital, Youngstown, Ohio, United States
S0010 506U78 in Treating Patients With Recurrent or Refractory Acute Lymphocytic Leukemia
- Conditions
- Leukemia
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2015-03-06
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 35
- Registration Number
- NCT00006020
- Locations
- 🇺🇸
CCOP - Atlanta Regional, Atlanta, Georgia, United States
🇺🇸CCOP - Columbus, Columbus, Ohio, United States
🇺🇸Boston Medical Center, Boston, Massachusetts, United States
S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer
- Conditions
- Prostate CancerGastric CancerBrain TumorsOvarian Cancer
- Interventions
- Biological: GMCSFBiological: KLH
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2015-03-06
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 14
- Registration Number
- NCT00023634
- Locations
- 🇺🇸
St. Joseph Hospital Community Cancer Center, Bellingham, Washington, United States
🇺🇸Olympic Hematology and Oncology, Bremerton, Washington, United States
🇺🇸Harborview Medical Center, Seattle, Washington, United States
S9811 Hydroxyurea in Treating Patients With Unresectable Benign Meningioma
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2016-05-20
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 29
- Registration Number
- NCT00003590
- Locations
- 🇺🇸
Graham Hospital, Canton, Illinois, United States
🇺🇸CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States
🇺🇸Mercy Hospital, Coon Rapids, Minnesota, United States
S0011, Gene Therapy & Surgery Followed by Chemo & RT in Newly Diagnosed Cancer of the Mouth or Throat
- Conditions
- Head and Neck Cancer
- Interventions
- Biological: Ad5CMV-p53 geneProcedure: conventional surgeryRadiation: radiation therapy
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2012-06-14
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 13
- Registration Number
- NCT00017173
- Locations
- 🇺🇸
Markey Cancer Center at University of Kentucky Chandler Medical Center, Lexington, Kentucky, United States
🇺🇸Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center, Kansas City, Kansas, United States
🇺🇸Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States